Lumexa Imaging Holdings, a diagnostic imaging provider with 184 outpatient centers across the US, filed on Monday with the SEC to raise what we estimate could be up to $200 million in an initial public offering.
Lumexa Imaging is a national provider of outpatient diagnostic imaging services, operating 184 centers across 13 states through a mix of wholly owned sites and joint ventures with health systems. The company offers a range of advanced and routing imaging modalities, spanning MRIs, CTs, PET scans, X-rays, ultrasounds, and mammograms. Formed in 2018 by Charlotte Radiology and Welsh, Carson, Anderson & Stowe, Lumexa expanded from 20 centers by completing 20 acquisitions and opening 41 de novo locations, and maintains a diversified network of about 100,000 referring physicians from more than 29,000 practices.
The Raleigh, NC-based company was founded in 2018 and booked $1.0 billion in revenue for the 12 months ended September 30, 2025. It plans to list on the Nasdaq under the symbol LMRI. Lumexa Imaging Holdings filed confidentially on June 12, 2025. Barclays, J.P. Morgan, Jefferies, Deutsche Bank, Wells Fargo Securities, Leerink Partners, William Blair, Capital One Securities, Fifth Third Securities, Raymond James, and PNC Capital Markets are the joint bookrunners on the deal. No pricing terms were disclosed.
